Lv6
2310 积分 2023-08-21 加入
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
3天前
已完结
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic Model
3天前
已完结
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
13天前
已完结
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial
17天前
已完结
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
20天前
已完结
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
20天前
已完结
Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial
1个月前
已完结
Long-term change in the target achievement rate of low-density lipoprotein cholesterol in patients with cardiovascular disease
1个月前
已关闭
皖公网安备34019202002308
